A detailed history of Campbell & CO Investment Adviser LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 17,584 shares of INVA stock, worth $312,643. This represents 0.03% of its overall portfolio holdings.

Number of Shares
17,584
Previous 22,976 23.47%
Holding current value
$312,643
Previous $376,000 9.84%
% of portfolio
0.03%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$16.33 - $20.04 $88,051 - $108,055
-5,392 Reduced 23.47%
17,584 $339,000
Q2 2024

Aug 13, 2024

SELL
$14.4 - $16.4 $2,001 - $2,279
-139 Reduced 0.6%
22,976 $376,000
Q1 2024

May 10, 2024

BUY
$14.56 - $16.78 $336,554 - $387,869
23,115 New
23,115 $352,000
Q3 2023

Nov 08, 2023

BUY
$12.37 - $13.89 $19,717 - $22,140
1,594 Added 11.01%
16,078 $208,000
Q2 2023

Aug 11, 2023

BUY
$11.39 - $13.72 $164,972 - $198,720
14,484 New
14,484 $184,000
Q4 2022

Feb 14, 2023

SELL
$11.8 - $13.78 $240,554 - $280,919
-20,386 Reduced 27.31%
54,248 $718,000
Q3 2022

Nov 14, 2022

BUY
$11.61 - $15.22 $562,411 - $737,287
48,442 Added 184.95%
74,634 $867,000
Q2 2022

Aug 09, 2022

SELL
$14.32 - $19.88 $143,128 - $198,700
-9,995 Reduced 27.62%
26,192 $387,000
Q1 2022

May 09, 2022

BUY
$15.39 - $20.25 $103,651 - $136,383
6,735 Added 22.87%
36,187 $700,000
Q4 2021

Feb 10, 2022

BUY
$15.91 - $18.72 $206,830 - $243,359
13,000 Added 79.02%
29,452 $508,000
Q3 2021

Nov 10, 2021

BUY
$13.06 - $17.24 $214,863 - $283,632
16,452 New
16,452 $275,000
Q3 2020

Oct 15, 2020

SELL
$10.33 - $14.49 $168,368 - $236,172
-16,299 Closed
0 $0
Q2 2020

Jul 29, 2020

BUY
$11.49 - $15.26 $187,275 - $248,722
16,299 New
16,299 $228,000
Q3 2019

Oct 16, 2019

SELL
$10.05 - $14.55 $228,426 - $330,706
-22,729 Closed
0 $0
Q2 2019

Jul 10, 2019

SELL
$13.1 - $14.95 $267,004 - $304,710
-20,382 Reduced 47.28%
22,729 $331,000
Q1 2019

May 10, 2019

BUY
$13.69 - $20.06 $590,189 - $864,806
43,111 New
43,111 $605,000
Q3 2018

Nov 08, 2018

SELL
$13.63 - $15.7 $515,377 - $593,648
-37,812 Closed
0 $0
Q2 2018

Jul 13, 2018

BUY
$13.44 - $17.59 $221,760 - $290,235
16,500 Added 77.42%
37,812 $522,000
Q1 2018

May 04, 2018

BUY
$13.8 - $16.99 $46,920 - $57,765
3,400 Added 18.98%
21,312 $355,000
Q4 2017

Feb 14, 2018

SELL
$11.73 - $14.75 $50,380 - $63,351
-4,295 Reduced 19.34%
17,912 $254,000
Q3 2017

Nov 13, 2017

BUY
$12.06 - $14.12 $267,816 - $313,562
22,207
22,207 $314,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.